Richmond, Virginia


Email Michael Phelan Michael Phelan on LinkedIn Michael Phelan on Facebook Michael Phelan on Avvo
Michael Phelan
Michael Phelan
Attorney • (866) 249-3164

More Bad News About Actos and Avandia

1 comment

Diabetic macular edema (DME) is a condition in which the retina thickens and swells. DME can lead to blindness. A new study of more than 100,000 people which was presented Sunday at the Amercan Diabetes Association’s annual meeting in San Diego concludes that people taking Actos or Avandia have a 3 to 6 times increased risk of developing diabetic macular edema.

Actos may also raise the risk of bladder cancer in patients who take the medicine more than a year, the FDA said in a June 16 safety announcement. The medicine has sales of 387.9 billion yen ($4.8 billion) in the fiscal year ended in March, according to Bloomberg data.

The treatment from Japan-based Takeda became the market leader after a 2007 study showed a 43 percent higher risk of heart attacks with Avandia from London-based Glaxo. Avandia’s sales declined to $680 million in 2010 after a high of about $3 billion. The FDA said in May that Glaxo’s medicine will be pulled from retail pharmacies in the U.S. and available only through a special program beginning in November.

1 Comment

Have an opinion about this post? Please consider leaving a comment or subscribing to the feed to have future articles delivered to your feed reader.

  1. Scott says:
    up arrow

    GSK manufacturer of Avandia, has engaged in a evidence tampering and judicial misconduct with the MDL 1871 Case, they have conspired with Pepper Hamilton to lie to Federal Judge, destroyed evidence, concealed documents, threatened witnesses and witness and evidence tampering in the cases against them. As one Pepper Hamilton legal assistance it is all about them billing millions to GSK to keep the cases going on delays and waiting to see how may victims die before settlements can be reached and the judge has been allowing the GSK lawyer to run the show.